Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

TRANSCAT INC (TRNS)

$84.85 -2.82% NASDAQ: TRNS · 15-min delayed
  • ROCHESTER, New York
  • Public · NASDAQ: TRNS
  • 1,413 employees
$819.4MMarket cap
$331.9MRevenue · FY2026
$5.4MNet income
1,413Employees
TRNSNASDAQ
1977IPO

About TRANSCAT INC

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$331.9M
Net income
$5.4M
Total assets
$480.5M
Market cap
$819.4M
Gross margin
32.6%
Operating margin
4.0%
Net margin
1.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2026

Financial statements

Income statement

Revenue
$331.9M
Cost of revenue
$223.6M
Gross profit
$108.3M
Operating expenses
$95.0M
Operating income
$13.3M
Income tax
$2.6M
Net income
$5.4M
EPS (basic)
$0.58
EPS (diluted)
$0.57

Balance sheet

Total assets
$480.5M
Current assets
$92.5M
Total liabilities
$179.9M
Current liabilities
$39.6M
Shareholders’ equity
$300.6M

Cash flow

Operating cash flow
$34.9M
Investing cash flow
-$97.8M
Financing cash flow
$66.5M
Net cash flow
$3.5M

Statements via Polygon.io (SEC filings)

NASDAQ: TRNS
$84.85 -2.82%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$52.06 $93.24

52-week range

Market cap
$819.4M
P/E ratio
148.9
EPS (diluted)
$0.57
Shares outstanding
9.7M
Open
Day range
Prev close
Volume
IPO date
Dec 5, 1977

Transcat Inc (TRNS) Stock Price

  • Profitable — net income of $5.4M in FY2026.
  • Revenue grew 62% from FY2022 to FY2026.
  • Gross margin of 32.6%, net margin 1.6%.
  • Trading 9% below its 52-week high.
  • Valued at a price-to-earnings (P/E) ratio of 148.9.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review TRANSCAT INC.

Write a review
Newsroom

News about TRANSCAT INC

News & sentiment via Polygon.io

FAQ

Transcat Inc: frequently asked questions

Is Transcat Inc an American company?

Transcat Inc is a US-based company headquartered in Rochester, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Transcat Inc headquartered?

Transcat Inc is headquartered in Rochester, New York, United States.

Is Transcat Inc publicly traded?

Yes — Transcat Inc is a publicly traded company. Its stock trades under the ticker symbol TRNS on the NASDAQ.

What does Transcat Inc do?

Transcat Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →